Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by De, P.
Right arrow Articles by Nair, H.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Review: Dual blockade of renin-angiotensin system in diabetic nephropathy: review of literature and local experience

Parijat De

Department of Diabetes and Endocrinology, City Hospital, Dudley Road, Birmingham, B18 7QH, UK, parijat.de{at}swbh.nhs.uk

Gautam Das

Karen Harley

Harikrishan Nair

Albuminuria and hypertension are predictors of poor renal and cardiovascular outcome in patients with diabetic nephropathy (DN). Intensive treatment requires blockade of the renin-angiotensin system (RAS) by either angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARB), which reduce blood pressure and proteinuria. Combining the two therapies has shown greater benefits than either drug alone to reduce progression of DN. Although treatment goals are more likely to be achieved with the combination, this requires close monitoring of serum creatinine and potassium which invariably rise on such therapy.

Key Words: diabetic nephropathy • dual blockade • blood pressure • resistant hypertension • urine albumin-creatinine blocker • creatinine • potassium. ratio • glomerular filtration rate • renin-angiotensin system • angiotensin-converting enzyme inhibitor • angiotensin receptor blocker • creatinine • potassium.

The British Journal of Diabetes & Vascular Disease, Vol. 6, No. 1, 23-28 (2006)
DOI: 10.1177/14746514060060010301
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 British Journal of Diabetes & Vascular DiseaseHome page
M. Kirby
Heart failure and diabetes in primary care
The British Journal of Diabetes & Vascular Disease, September 1, 2006; 6(5): 220 - 228.
[Abstract] [PDF]